CMB — Cambium Bio Balance Sheet
0.000.00%
- AU$3.85m
- AU$3.78m
- AU$0.13m
Annual balance sheet for Cambium Bio, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1.55 | 5.86 | 0.164 | 0.303 | 2.86 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.92 | 0.84 | 0.559 | 0.39 | 0.257 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3.48 | 6.73 | 0.787 | 2.46 | 3.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.08 | 0.034 | 0.017 | 0.001 | 0 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 3.56 | 8.51 | 2.55 | 2.46 | 5.65 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.63 | 1.3 | 1.48 | 2.59 | 2.4 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.7 | 4.36 | 1.48 | 2.59 | 2.87 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.131 | 4.15 | 1.07 | -0.125 | 2.78 |
Total Liabilities & Shareholders' Equity | 3.56 | 8.51 | 2.55 | 2.46 | 5.65 |
Total Common Shares Outstanding |